Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL
Phase 1
Not yet recruiting
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Israeli Medical Association
- Target Recruit Count
- 48
- Registration Number
- NCT05054465
- Locations
- 🇮🇱
Soroka Medical Center, Be'er Sheva, Israel
🇮🇱Rambam Health Care Campus, Haifa, Israel
🇮🇱Shaare Zedek Medical Center, Jerusalem, Israel
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
- First Posted Date
- 2020-04-06
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Israeli Medical Association
- Target Recruit Count
- 110
- Registration Number
- NCT04334993
- Locations
- 🇮🇱
Rambam Medical Center, Haifa, Israel
🇮🇱Shaarei Tzedek Medical Center, Jerusalem, Israel
🇮🇱Rabin Medical Center, Petah Tikva, Israel
News
No news found